Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL4609718 | 1.00 | TSHR (0.56) | TSHRALDH1A1MAPK1TDP1ALOX15 | |
| Ether SCHEMBL28161425 | 0.94 | TSHR (0.50) | TSHRALDH1A1ALOX15CYP2C9 | |
| Ether SCHEMBL8913501 | 0.92 | TSHR (0.47) | TSHRALDH1A1ALOX15CYP2C9 | |
| Ether SCHEMBL18985182 | 0.89 | TSHR (0.45) | TSHRALDH1A1ALOX15CYP2C9 | |
| Dimethylformamide SCHEMBL28207129 | 0.88 | TSHR (0.50) | TSHRALDH1A1ALOX15 | |
| Ether SCHEMBL28347512 | 0.87 | TSHR (0.43) | TSHRALDH1A1CYP2C9 | |
| Ether SCHEMBL27748257 | 0.87 | TSHR (0.43) | TSHR | |
| Dimethylformamide SCHEMBL10802383 | 0.86 | TSHR (0.47) | TSHRALDH1A1ALOX15 | |
| Ether SCHEMBL8895247 | 0.83 | TSHR (0.39) | TSHR | |
| Tetrahydrofuran SCHEMBL10573397 | 0.82 | TSHR (0.38) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107954822-A | A kind of method for preparing diaryl acetylene compound | 浙江大学 | 2018-04-24 | — | — | CN | claimed |
| EP-1688410-B1 | CRYSTAL OF PHENYLALANINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | AJINOMOTO KK (JP) | 2014-03-05 | — | — | EP | claimed |
| EP-1688410-A1 | CRYSTAL OF PHENYLALANINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | Ajinomoto Co., Inc. (JP) | 2006-08-09 | — | — | EP | claimed |
| EP-0478874-A2 | Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them | AMERICAN CYANAMID COMPANY (US) | 1992-04-08 | — | — | EP | claimed |
| EP-0046658-B1 | PRODUCTION OF TRIAZOLYLVINYL KETONES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-10-24 | — | — | EP | claimed |
| EP-0005524-A1 | Omega-(1,3-dithiolan-2-imino)substituted acetic acids, process for their preparation and pharmaceutical compositions containing them | MERRELL DOW PHARMACEUTICALS, INC. (US) | 1979-11-28 | — | — | EP | claimed |
| WO-2023133876-A1 | FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF | 嘉庚创新实验室 | 2023-07-20 | — | — | WO | disclosed |
| US-20220071917-A9 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2022-03-10 | — | — | US | disclosed |
| US-20210228494-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2021-07-29 | — | — | US | disclosed |
| EP-3703666-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | Universidade de Santiago de Compostela (ES) | 2020-09-09 | — | — | EP | disclosed |
| CN-110431520-A | Conductive film, touch panel and image display device | DAINIPPON PRINTING CO LTD | 2019-11-08 | — | — | CN | disclosed |
| CN-110337475-A | Membrane with hydrophobically modified cellulose fibers and oil | 花王株式会社 | 2019-10-15 | — | — | CN | disclosed |
| CN-109275335-B | The manufacturing method of composition and composition | 住友化学株式会社 | 2019-10-15 | — | — | CN | disclosed |
| US-4271068-A | Process for the manufacture of cystine-containing peptides | CIBA-GEIGY CORPORATION (US) | 1981-06-02 | — | — | US | disclosed |
| US-4260774-A | IMMUNOSUPPRESSANTS, ANTITUMOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-04-07 | — | — | US | disclosed |
| US-4172892-A | Heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acid | CARLO ERBA S.P.A. (IT) | 1979-10-30 | — | — | US | disclosed |
| US-4159981-A | CYCLIC POLYPEPTIDES, DEETHERIFICATION, DEESTERIFICATION | CIBA-GEIGY CORPORATION (US) | 1979-07-03 | — | — | US | disclosed |
| US-4154830-A | ANTIBIOTICS, BACTERICIDES FOR INFECTIONS | CARLO ERBA S.P.A. (IT) | 1979-05-15 | — | — | US | disclosed |
| US-4103089-A | ANTIHISTAMINES | MERRELL TORAUDE ET COMPAGNIE (FR) | 1978-07-25 | — | — | US | disclosed |
| US-3934008-A | PEPTIDES, HYPOCALCAEMIC | CIBA-GEIGY CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228494-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | LNPEP, CLIC1, CLSPN | TSHR 1863/4885ALDH1A1 2263/4885MAPK1 3530/4885 |
| US-20220071917-A9 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | LNPEP, CLIC1, CLSPN | TSHR 1863/4885ALDH1A1 2263/4885MAPK1 3530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.